S&T Bank Organon & Co. Transaction History

S&T Bank

$309 Million
Q2 2025

A detailed history of S&T Bank transactions in Organon & Co. stock. As of the latest transaction made, S&T Bank holds 22 shares of OGN stock, worth $148. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 32 31.25%

Holding current value

$148

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$8.04 - $14.72 $80 - $147	-10 Reduced 31.25%	22 $0
Q1 2025 May 15, 2025	BUY	$14.29 - $16.41 $314 - $361	22 Added 220.0%	32 $0
Q4 2024 Feb 14, 2025	BUY	$14.44 - $18.83 $144 - $188	10 New	10 $0

Others Institutions Holding OGN

# of Institutions

798

Shares Held

208M

Call Options Held

2.74M

Put Options Held

1.79M

Black Rock Inc. New York, NY

32.6M
Shares

$220 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

32.3M
Shares

$218 Million
0.01% of portfolio
State Street Corp Boston, MA

9.52M
Shares

$64.3 Million
0.0% of portfolio
Massachusetts Financial Services CO Boston, MA

9.5M
Shares

$64.1 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

9.09M
Shares

$61.4 Million
0.05% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $1.72B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.

Account